Table 2.
Age-Sex Standardized Mean Annual Incidence Rate by Varicella Vaccine Availability Periods
| Age-Sex Standardized Incidence Rate per 1000 Population (95 % Confidence Interval) | ||||
|---|---|---|---|---|
| Pre-licensure (1997–1998) | Privately Funded (1999–2004) | Publicly Funded (2005–2012) | Overall (1997–2012) | |
| HZ | 3.175 (3.134, 3.217) |
3.244 (3.221, 3.267) |
3.869 (3.849, 3.890) |
3.575 (3.561, 3.589) |
| HZ with Antiviral | 1.678 (1.648, 1.709) |
1.926 (1.908, 1.944) |
2.571 (2.554, 2.587) |
2.242 (2.231, 2.254) |
| PHN within 90 days | 0.127 (0.119, 0.135) |
0.169 (0.164, 0.175) |
0.271 (0.266, 0.277) |
0.221 (0.217, 0.224) |
| PHN within 30 days | 0.104 (0.097, 0.112) |
0.141 (0.136, 0.146) |
0.232 (0.227, 0.237) |
0.187 (0.184, 0.191) |